BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
IGF1
,
T cell receptor signaling pathway
,
HIV infection
,
Liver
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
classical hodgkin lymphoma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Classical Hodgkin lymphoma and B-cell lymphoma cell lines expression profiles
Lymphomas from classical Hodgkin's lymphoma patients
Molecular profiling of classical Hodgkin’s lymphoma tissues
Lymphocyte predominant Hodgkin lymphoma and its relationship to other lymphomas
DLBCL cells with different oncogenic mutations
Explore Curated Studies Results
Literature
Most Relevant Literature
Concomitant lymphocyte-rich classical Hodgkin's lymphoma and Warthin's tumor.
Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyt…
Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome…
Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 pat…
Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lympho…
Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ